Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Trazodone on Sleep Apnea Severity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria for OSA Patients:~* OSA (elevated AHI).~* Age range 18-70 years.~Exclusion Criteria:~* Any known cardiac (apart from treated hypertension), pulmonary (including asthma), renal, neurologic (including epilepsy), neuromuscular, or hepatic disease.~* Susceptible to stomach ulcers.~* Pregnant women.~* History of hypersensitivity to Afrin, Lidocaine, trazodone and/or donepezil.~* History of bleeding diathesis and/or gastrointestinal bleeding.~* Use of any medications that may affect sleep or breathing.~* A psychiatric disorder, other than mild depression; e.g. schizophrenia, bipolar disorder, major depression, panic or anxiety disorders.~* Substantial cigarette (\>5/day), alcohol (\>3oz/day) or use of illicit drugs.~* More than 10 cups of beverages with caffeine (coffee, tea, soda/pop) per day.~* Desaturations to below 70% lasting greater than 10 seconds in duration per event on polysomnography.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Subjects will receive a sugar pill during their placebo night sleep study.
- Trazodone (Type: ACTIVE_COMPARATOR): Subjects will receive trazodone during their treatment night sleep study

Based on this trial design, predict the completion outcome and termination type (if applicable).